One in seven people with ANCA-associated vasculitis (AAV) has renal arteritis, or inflammation of the small arteries in the kidney, and this condition appears to be associated with an increased risk of kidney failure, a multicenter study in China showed. “The presence of renal arteritis may represent a widespread…
Discussion
Higher levels of the complement protein C5a in urine may provide a noninvasive way of identifying more severe kidney involvement and a greater likelihood of poor outcomes in people with ANCA-associated vasculitis (AAV), a study suggests. In an unadjusted analysis, high urinary C5a was associated with a 3.73-fold higher…
Discussion
Patient advocates are preparing for the potential withdrawal of Tavneos (avacopan) for ANCA-associated vasculitis (AAV) in the U.K. as regulators there and in the U.S. weigh whether to pull the plug on the therapy’s approval. Authorities in the European Union have…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
